- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.09. | Sight Sciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| SIGHT SCIENCES Aktie jetzt für 0€ handeln | |||||
| 17.09. | Sight Sciences reports positive data for Omni surgical system | 1 | MassDevice | ||
| 17.09. | Sight Sciences' OMNI system shows strong results in glaucoma treatment | 1 | Investing.com | ||
| 17.09. | Sight Sciences, Inc.: Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use | 4 | GlobeNewswire (USA) | ||
| 10.09. | Sight Sciences auf Morgan-Stanley-Konferenz: Strategischer Fokus auf Wachstum | - | Investing.com Deutsch | ||
| 09.09. | UnitedHealthcare Adds Sight Sciences OMNI System To Covered Glaucoma Surgery Procedures | 18 | Benzinga.com | ||
| 09.09. | Sight Sciences, Inc.: Sight Sciences Announces the OMNI Surgical System to be Included in UnitedHealthcare's Expanded Coverage of Glaucoma Surgical Treatments | 169 | GlobeNewswire (Europe) | MENLO PARK, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing... ► Artikel lesen | |
| 02.09. | Sight Sciences, Inc.: Sight Sciences Announces Recognition of the TearCare System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO | 1 | GlobeNewswire (USA) | ||
| 27.08. | Sight Sciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.08. | What 4 Analyst Ratings Have To Say About Sight Sciences | 1 | Benzinga.com | ||
| 08.08. | Sight Sciences stock rating upgraded by Lake Street on stabilizing business | 3 | Investing.com | ||
| 08.08. | Sight Sciences raises 2025 revenue guidance to $72M-$76M amid strong OMNI growth and strategic focus on MIGS leadership | 1 | Seeking Alpha | ||
| 30.07. | Sight Sciences, Inc.: Sight Sciences Announces the Results of a Cost-Utility Analysis Demonstrating Cost Savings and Greater Health Utility with the TearCare System Compared to Cyclosporine 0.05% for Treating Meibomian Gland Disease-Associated ... | 2 | GlobeNewswire (USA) | ||
| 29.07. | Sight Sciences, Inc.: Sight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare Procedure for the Treatment of Dry Eye Disease | 1 | GlobeNewswire (USA) | ||
| 24.07. | Sight Sciences, Inc.: Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025 | 2 | GlobeNewswire (USA) | ||
| 15.07. | The Analyst Verdict: Sight Sciences In The Eyes Of 4 Experts | 2 | Benzinga.com | ||
| 18.06. | Piper Sandler raises Sight Sciences price target to $4 on technology outlook | 1 | Investing.com | ||
| 05.06. | Sight Sciences ernennt neues Vorstandsmitglied und hält Jahresversammlung ab | 2 | Investing.com Deutsch | ||
| 05.06. | Sight Sciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.05. | Sight Sciences auf dem Stifel-Forum: Strategisches Wachstum trotz Herausforderungen | 2 | Investing.com Deutsch |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,310 | -0,62 % | Fresenius SE - Range im Fokus | ||
| SIEMENS HEALTHINEERS | 48,530 | +0,43 % | SIEMENS HEALTHINEERS versucht die Börsenpräsenz zu erweitern | SIEMENS ist bereit, bis 51 % zu reduzieren. Das ergäbe ein Emissionsvolumen von geschätzt 17 bis 18 Mrd. € gegenüber dem aktuellen Stand. Aus München verlautet, dass es dafür kein Börsenkonsortium gibt... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 46,250 | +1,16 % | JEFFERIES stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für FMC nach einem Treffen mit Unternehmenschefin Helen Giza mit einem Kursziel von 36 Euro auf "Underperform" belassen. Der... ► Artikel lesen | |
| GERRESHEIMER | 37,180 | -2,11 % | Almonty Industries, Gerresheimer, BASF - Noch ist es nicht zu spät! | Der Wettlauf um wichtige Güter aus der Hightechindustrie und um Rohstoffe hat längst begonnen. Die Corona Pandemie hat uns schmerzlich vor Augen geführt, was die Nachteile einer global vernetzten Wirtschaft... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 45,080 | -1,18 % | Carl Zeiss Meditec AG: ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization | Showcasing at AAO 2025:
NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 28,430 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| ENVOY MEDICAL | 1,600 | 0,00 % | Envoy Medical, Inc.: Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data | White Bear Lake, Minnesota--(Newsfile Corp. - October 7, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions... ► Artikel lesen | |
| CLEARPOINT NEURO | 26,400 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles | SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 7, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,985 | -0,73 % | Alignment Healthcare USA, LLC: Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors | ORANGE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced its 2026 product portfolio, offering 68... ► Artikel lesen | |
| ECKERT & ZIEGLER | 17,570 | -1,13 % | Eckert & Ziegler unter Druck - ist das der Beginn einer längeren Talfahrt?!! | ||
| KINDLY MD | 1,015 | 0,00 % | KindlyMD, Inc: KindlyMD Announces Strategic Partnership with Antalpha and Intent to Establish $250 Million Convertible Debt Facility | First Step in Broader Effort to Develop Innovative Financing Tools for the Bitcoin MarketCollaboration Launches Initial Treasury Financing Structure SALT LAKE CITY, UTAH / ACCESS Newswire / October... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 34,610 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PROGYNY | 19,990 | -1,02 % | Progyny, Inc.: Progyny CEO Named World Economic Forum Champion for Women's Health | ||
| ONEMEDNET | 2,600 | 0,00 % | Onemednet stock soars, Palantir shares rise on AI healthcare partnership | ||
| SANUWAVE HEALTH | 32,050 | 0,00 % | SANUWAVE Health, Inc.: Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025) | Sanuwave announces preliminary revenues of $11.4 million to $11.6 million for the third quarter ended September 30, 2025. This represents the highest quarterly revenues in Company history. Q3 2025... ► Artikel lesen |
SIGHT SCIENCES INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +2,98 % bei einem Aktienkurs von 3,460 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SIGHT SCIENCES INC finden Sie auf Wallstreet Online.